CME
Cme Group Inc.Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| adjusted operating income non-GAAP | 1.4B | Q1 2026 | — |
| Non-U.S. average daily volume | 11.4M | Q1 2026 | — |
|
|
|||
| total average rate per contract | $0.65 | Q1 2026 | — |
| adjusted expenses non-GAAP | $512M | Q1 2026 call | — |
| adjusted expenses excluding license fees non-GAAP | $405M | Q1 2026 call | — |
| adjusted net income non-GAAP | $1.2B | Q1 2026 call | — |
| adjusted net income margin non-GAAP | 64.9% | Q1 2026 call | — |
| adjusted operating margin non-GAAP | 72.8% | Q1 2026 call | — |
| average daily volume | 36.2M | Q1 2026 call | — |
| average rate per contract | $0.65 | Q1 2026 call | — |
|
|
|||
| capital returned to shareholders | $3.2B | Q1 2026 call | — |
| market data revenue | $224M | Q1 2026 call | — |
|
|
|||
| shares repurchased | $536M | Q1 2026 call | — |
| U.S. treasury open interest | 36.3M | Q1 2026 call | — |
| variable and regular quarterly dividends | $2.7B | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CME
this stock
Cme Group Inc.
|
$88.99B | -8.1% | +11.1% | 21.0 | 1.7% |
|
SPGI
S&P Global Inc.
|
$131.06B | -9.7% | +7.1% | 29.6 | 1.2% |
|
MCO
Moodys Corp /De/
|
$88.21B | -1.0% | +16.6% | 36.2 | 1.7% |
|
ICE
Intercontinental Exchange, Inc.
|
$80.32B | -13.4% | -2.1% | 20.3 | 1.9% |
|
LSEGY
London Stock Exchange Group plc
|
$59.79B | +0.1% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CME | +0.9% | -8.6% | -10.0% | +11.0% | -8.1% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | -0.4% | -8.4% | -20.2% | +10.0% | -18.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.